Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
Director
-
Issuer Symbol
-
DNLI on Nasdaq
BAKER BROS. ADVISORS LP - trading volume in the past year for Denali Therapeutics Inc.
Holdings reported by BAKER BROS. ADVISORS LP for Denali Therapeutics Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| $0.01 Prefunded Warrants |
25,996,310 |
$454,675,461 |
$17.49 |
11 Dec 2025 |
Indirect |
Common Stock |
|
| Common Stock |
3,415,958 |
$56,158,349 |
$16.44 |
03 Jun 2025 |
Indirect |
|
|
| Non- Qualified Stock Option (right to buy) |
31,695 |
|
|
03 Jun 2025 |
Indirect |
Common Stock |
|
| Non-Qualified Stock Option (right to buy)uy) |
31,695 |
|
|
03 Jun 2025 |
Indirect |
Common Stock |
|
Transactions reported by BAKER BROS. ADVISORS LP for Denali Therapeutics Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.